Short-term reproducibility of impaired fasting glycaemia, impaired glucose tolerance and diabetes. The ADDITION study, DK

Diabetes Research and Clinical Practice

Volumn 80, Issue 1, 2008, Pages 146-152

  Rasmussen, S S ^a   Glumer C ^b   Sandbaek, A ^c   Lauritzen, T ^c   Carstensen, B ^a   Borch Johnsen, K ^a,c  

^a STENO DIABETES CENTER   (Denmark)

^b Research Centre for Prevention and Health   (Denmark)

^c AARHUS UNIVERSITY   (Denmark)

Author keywords

Capillary blood glucose; Impaired fasting glycaemia; Impaired glucose tolerance; Intra individual variation; Type 2 diabetes

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL STUDY; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIET RESTRICTION; DISEASE CLASSIFICATION; GENERAL PRACTICE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HIGH RISK POPULATION; HUMAN; IMPAIRED FASTING GLYCEMIA; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; REPRODUCIBILITY; RESCREENING; SCREENING TEST; STATISTICAL PARAMETERS;

AGED; BLOOD GLUCOSE; BLOOD SPECIMEN COLLECTION; CAPILLARIES; CHEMISTRY, CLINICAL; DIABETES MELLITUS, TYPE 2; FASTING; FEMALE; GLUCOSE INTOLERANCE; HUMANS; HYPERGLYCEMIA; MALE; MASS SCREENING; MIDDLE AGED; PREDIABETIC STATE; REPRODUCIBILITY OF RESULTS; RISK FACTORS;

EID: 40849115002     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2007.11.003     Document Type: Article

References (25)

1. World Health Organization, Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications. Part 1: Diagnosis and Classification of Diabetes Mellitus. Report of a WHO Consultation, Geneva, 1999.
2. West K.M., Wulff J.A., Reigel D.G., and Fitzgerald D.T. Oral carbohydrate tolerance tests. Arch. Intern. Med. 113 (1964) 641-648
3. Ganda O.P., Day J.L., Soeldner J.S., Connon J.J., and Gleason R.E. Reproducibility and comparative analysis of repeated intravenous and oral glucose tolerance tests. Diabetes 27 (1978) 715-725
4. Godsland I.F. Intra-individual variation: significant changes in parameters of lipid and carbohydrate metabolism in the individual and intra-individual variation in different test populations. Ann. Clin. Biochem. 22 (1985) 618-624
5. Cummings S.T., and Fraser C.G. Variability of capillary plasma glucose in healthy individuals in repeated 75 g oral glucose tolerance tests. Ann. Clin. Biochem. 25 (1988) 634-637
6. Home P. The OGTT: gold that does not shine. Diab. Med. 5 (1988) 313-314
7. Schousboe K., Henriksen J.E., Kyvik K.O., Sorensen T.I., and Hyltoft P.P. Reproducibility of S-insulin and B-glucose responses in two identical oral glucose tolerance tests. Scand. J. Clin. Lab. Invest. 62 (2002) 623-630
8. Feskens E.J., Bowles C.H., and Kromhout D. Intra- and interindividual variability of glucose tolerance in an elderly population. J. Clin. Epidemiol. 44 (1991) 947-953
9. Swai A.B., McLarty D.G., Kitange H.M., Kilima P.M., Masuki G., Mtinangi B.I., et al. Study in Tanzania of impaired glucose tolerance. Methodological myth?. Diabetes 40 (1991) 516-520
10. Mooy J.M., Grootenhuis P.A., de Vries H., Kostense P.J., Popp-Snijders C., Bouter L.M., et al. Intra-individual variation of glucose, specific insulin and proinsulin concentrations measured by two oral glucose tolerance tests in a general Caucasian population: the Hoorn Study. Diabetologia 39 (1996) 298-305
11. Sievenpiper J.L., Leiter L.A., and Vuksan V. Intrasubject coefficient of variation corresponds to diagnostic reproducibility in diabetes screening. Can. J. Diab. 26 (2002) 105-112
12. Brohall G., Behre C.J., Hulthe J., Wikstrand J., and Fagerberg B. Prevalence of diabetes and impaired glucose tolerance in 64-year-old Swedish women: experiences of using repeated oral glucose tolerance tests. Diab. Care 29 (2006) 363-367
13. Christensen J.O., Sandbaek A., Lauritzen T., and Borch-Johnsen K. Population-based stepwise screening for unrecognised Type 2 diabetes is ineffective in general practice despite reliable algorithms. Diabetologia 47 (2004) 1566-1573
14. Lauritzen T., Griffin S., Borch-Johnsen K., Wareham N.J., Wolffenbuttel B.H., and Rutten G. The ADDITION study: proposed trial of the cost-effectiveness of an intensive multifactorial intervention on morbidity and mortality among people with Type 2 diabetes detected by screening. Int. J. Obestet. Relat. Metab. Disord. 24 Suppl. 3 (2000) S6-S11
15. Sandbaek A., Lauritzen T., Borch-Johnsen K., Mai K., and Christiansen J.S. The comparison of venous plasma glucose and whole blood capillary glucose in diagnoses of Type 2 diabetes: a population-based screening study. Diab. Med. 22 (2005) 1173-1177
16. Bland J.M., and Altman D.G. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1 (1986) 307-310
17. Bland J.M., and Altman D.G. Measuring agreement in method comparison studies. Stat. Methods Med. Res. 8 (1999) 135-160
18. Carstensen B. Comparing and predicting between several methods of measurement. Biostatistics 5 (2004) 399-413
19. S. Sturtz, U. Ligges, A. Gelman, R2WinBUGS: Running WinBUGS and OpenBUGS from R. 2006 http://mirrors.dotsrc.org/cran/doc/vignettes/R2WinBUGS/R2WinBUGS.pdf accessed 1st February 2007.
20. B. Carstensen, J. Lindstrom, J. Sundvall, K. Borch-Johnsen, J. Tuomilehto, and the DPS study group. Measurement of blood glucose: comparison between different types of specimens, Ann. Clin. Biochem., in press.
21. Rassam A.G., Mcleod J., Burge M.R., and Schade D.S. Use of the HemoCue blood glucose analyzer in research studies. Diab. Care 21 (1998) 1369-1370
22. Chiasson J.L., Josse R.G., Gomis R., Hanefeld M., Karasik A., Laakso M., and STOP-NIDDM Trial REsearch Group. Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet 359 (2002) 2072-2077
23. Knowler W.C., Barrett-Connor E., Fowler E.S.E., Hamman R.F., Lachin J.M., Walker E.A., et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N. Engl. J. Med. 346 (2002) 393-403
24. Pan X.R., Li G.W., Hu Y.H., Wang J.X., Yang W.Y., An Z.X., et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diab. Care 20 (1997) 537-544
25. Tuomilehto J., Lindstrom J., Eriksson J.G., Valle T.T., Hamalainen H., Ilanne-Parikka P., et al., Finnish Diabetes Prevention Study Group. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N. Engl. J. Med. 344 (2001) 1343-1350